REG - Societe Generale SA BAWAG Group AG - Form 8.3 - BAWAG Group AG
Yesterday 13:45
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260402:nRSB3052Za&default-theme=true
RNS Number : 3052Z Societe Generale SA 02 April 2026
Ap27
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH
TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
1. KEY INFORMATION
(a) Full name of discloser SOCIETE GENERALE SA
(b) Owner or controller of interests and short positions disclosed, if BAWAG Group AG
different from 1(a)
The naming of nominee or vehicle companies is insufficient. For a trust, the
trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this
form relates
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an offeror/offeree, state
this and specify identity of offeror/offeree (Note 1)
(e) Date position held/dealing undertaken 01/04/2026
For an opening position disclosure, state the latest practicable date prior to
the disclosure
(f) In addition to the company in 1(c) above, is the discloser also Yes: Permanent TSB Group Holdings plc
making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 2
for each additional class of relevant security.
Ap28
Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)
(Note 2)
Class of relevant security €0.01 ordinary shares
(Note 3)
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled 337,582 0.44 82,158 0.11
(2) Cash-settled derivatives 339,167 0.44 499,111 0.65
(3) Stock-settled derivatives (including options) and agreements to 0 0.00 0 0.00
purchase/ sell
Total *879,590 1.14 581,269 0.75
*Include the holding of 202,841 shares on borrow products.
Details of options including rights to subscribe for new securities and any
open stock-settled derivative positions (including traded options), or
agreements to purchase or sell relevant securities, should be given on a
Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE
DISCLOSURE (Note 4)
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security
securities
EUR (Note 5)
€0.01 ordinary shares Purchase 231 133.9
€0.01 ordinary shares Purchase 92 133.9
€0.01 ordinary shares Purchase 249 132.4
€0.01 ordinary shares Purchase 150 133.4
€0.01 ordinary shares Purchase 2 133.5
€0.01 ordinary shares Purchase 4 133.7
€0.01 ordinary shares Purchase 15 133.5
€0.01 ordinary shares Purchase 19 132.8
€0.01 ordinary shares Purchase 20 132.7
€0.01 ordinary shares Purchase 25 133.1
€0.01 ordinary shares Purchase 26 133.6
€0.01 ordinary shares Purchase 26 133.7
€0.01 ordinary shares Purchase 28 133.8
€0.01 ordinary shares Purchase 30 133.7
€0.01 ordinary shares Purchase 35 133
€0.01 ordinary shares Purchase 38 133.7
€0.01 ordinary shares Purchase 38 133.8
€0.01 ordinary shares Purchase 39 133.7
€0.01 ordinary shares Purchase 59 134.3
€0.01 ordinary shares Purchase 61 133.9
€0.01 ordinary shares Purchase 66 133.9
€0.01 ordinary shares Purchase 74 133
€0.01 ordinary shares Purchase 102 134.4
€0.01 ordinary shares Purchase 128 134.1
€0.01 ordinary shares Purchase 138 133.2
€0.01 ordinary shares Purchase 1 132.7
€0.01 ordinary shares Purchase 2 133.3
€0.01 ordinary shares Purchase 8 133.7
€0.01 ordinary shares Purchase 8 133.7
€0.01 ordinary shares Purchase 19 132.7
€0.01 ordinary shares Purchase 20 132.6
€0.01 ordinary shares Purchase 21 132.7
€0.01 ordinary shares Purchase 21 133.2
€0.01 ordinary shares Purchase 22 133.5
€0.01 ordinary shares Purchase 27 133.7
€0.01 ordinary shares Purchase 29 133.7
€0.01 ordinary shares Purchase 30 133.7
€0.01 ordinary shares Purchase 33 134.2
€0.01 ordinary shares Purchase 37 134
€0.01 ordinary shares Purchase 47 133.3
€0.01 ordinary shares Purchase 50 132.6
€0.01 ordinary shares Purchase 63 133.7
€0.01 ordinary shares Purchase 1 133.1
€0.01 ordinary shares Purchase 3 133.7
€0.01 ordinary shares Purchase 6 133.7
€0.01 ordinary shares Purchase 9 133.7
€0.01 ordinary shares Purchase 15 133.7
€0.01 ordinary shares Purchase 19 132.7
€0.01 ordinary shares Purchase 19 133.1
€0.01 ordinary shares Purchase 19 133.7
€0.01 ordinary shares Purchase 22 133.9
€0.01 ordinary shares Purchase 24 132.5
€0.01 ordinary shares Purchase 24 133.5
€0.01 ordinary shares Purchase 25 133.1
€0.01 ordinary shares Purchase 43 133.9
€0.01 ordinary shares Purchase 15 133.3
€0.01 ordinary shares Purchase 15 133.3
€0.01 ordinary shares Purchase 15 133.4
€0.01 ordinary shares Purchase 15 133.5
€0.01 ordinary shares Purchase 15 133.6
€0.01 ordinary shares Purchase 15 133.6
€0.01 ordinary shares Purchase 15 133.7
€0.01 ordinary shares Purchase 15 133.7
€0.01 ordinary shares Purchase 15 133.9
€0.01 ordinary shares Purchase 15 134
€0.01 ordinary shares Purchase 15 134.1
€0.01 ordinary shares Purchase 16 133.1
€0.01 ordinary shares Purchase 16 133.1
€0.01 ordinary shares Purchase 18 133.2
€0.01 ordinary shares Purchase 18 133.5
€0.01 ordinary shares Purchase 21 133.7
€0.01 ordinary shares Purchase 21 133.8
€0.01 ordinary shares Purchase 24 133.7
€0.01 ordinary shares Purchase 24 133.8
€0.01 ordinary shares Purchase 27 133.5
€0.01 ordinary shares Purchase 27 133.8
€0.01 ordinary shares Purchase 28 132.5
€0.01 ordinary shares Purchase 28 133.5
€0.01 ordinary shares Purchase 29 133.7
€0.01 ordinary shares Purchase 29 133.9
€0.01 ordinary shares Purchase 33 133.6
€0.01 ordinary shares Purchase 37 133.4
€0.01 ordinary shares Purchase 37 133.7
€0.01 ordinary shares Purchase 39 133.7
€0.01 ordinary shares Purchase 40 133.5
€0.01 ordinary shares Purchase 46 133.5
€0.01 ordinary shares Purchase 47 133.4
€0.01 ordinary shares Purchase 73 133.8
€0.01 ordinary shares Purchase 109 132.4
€0.01 ordinary shares Purchase 92 134.6
€0.01 ordinary shares Purchase 46 132.8
€0.01 ordinary shares Purchase 46 134.5
€0.01 ordinary shares Purchase 369 132.4
€0.01 ordinary shares Purchase 143 132.4
€0.01 ordinary shares Sale 286 132.3989
€0.01 ordinary shares Sale 332 132.3922
€0.01 ordinary shares Sale 165 132.3856
€0.01 ordinary shares Sale 185 132.4
€0.01 ordinary shares Sale 92 133.9
€0.01 ordinary shares Sale 203 132.4
€0.01 ordinary shares Sale 185 132.4
€0.01 ordinary shares Sale 92 132.4
€0.01 ordinary shares Sale 92 132.4
€0.01 ordinary shares Sale 185 132.4
€0.01 ordinary shares Sale 231 132.4
€0.01 ordinary shares Sale 40 133.9
€0.01 ordinary shares Sale 5 133.5
€0.01 ordinary shares Sale 124 132.4
€0.01 ordinary shares Sale 1,883 132.4
€0.01 ordinary shares Sale 63 134
€0.01 ordinary shares Sale 83 133.6
€0.01 ordinary shares Sale 67 132.8
€0.01 ordinary shares Sale 11 133.6
Ap29
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price
relevant
description
e.g. opening/ closing a long/ short position, increasing/ reducing a long/
reference
per unit EUR
security
e.g. CFD short position
securities
(Note 5)
(Note 6)
€0.01 ordinary shares CFD Increasing a long position 286 132.39885
€0.01 ordinary shares CFD Reducing a short position 332 132.39223
€0.01 ordinary shares CFD Reducing a short position 165 132.38558
€0.01 ordinary shares Listed Call Warrant Increasing a long position 10 27.8
€0.01 ordinary shares Listed Call Warrant Increasing a long position 11.5 23.9
€0.01 ordinary shares Listed Call Warrant Increasing a long position 4 24.2
€0.01 ordinary shares Listed Call Warrant Increasing a long position 103.5 4.4
€0.01 ordinary shares Listed Call Warrant Increasing a long position 103.5 4.4
€0.01 ordinary shares Listed Call Warrant Increasing a long position 108 10.8
€0.01 ordinary shares Listed Call Warrant Increasing a long position 108 10.8
€0.01 ordinary shares Listed Call Warrant Increasing a short position 25.3 47.7
€0.01 ordinary shares Listed Call Warrant Increasing a short position 12.7 23.6
€0.01 ordinary shares Listed Call Warrant Increasing a short position 10 25
€0.01 ordinary shares Listed Call Warrant Increasing a short position 8 10.8
€0.01 ordinary shares Listed Call Warrant Increasing a short position 93.5 4.4
€0.01 ordinary shares Listed Call Warrant Increasing a short position 108 10.8
€0.01 ordinary shares Listed Call Warrant Increasing a short position 103.5 4.4
€0.01 ordinary shares Listed Call Warrant Increasing a short position 103.5 4.4
€0.01 ordinary shares Listed Call Warrant Increasing a short position 108 10.8
(c) Stock-settled derivative transactions (including
options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, purchasing, selling, varying Number Exercise Type Expiry Option
relevant description e.g. call etc. of
price per e.g. date money
security option securities unit American,
paid/
to which European received per unit
option
etc.
relates
(Note 6)
(ii) Exercise
Class of Product Exercising/ Number of Exercise
relevant description exercised securities price per
security e.g. call against unit
option (Note 5)
(d) Other dealings (including transactions in respect of
new securities) (Note 3)
Class of Nature of dealing Details Price per unit (if
relevant e.g. subscription, applicable)
security conversion, exercise (Note 5)
Ap30
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the person
making the disclosure and any party to the offer or any person acting in
concert with a party to the offer.
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to
options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
(c) Attachments
Is a Supplemental Form 8 attached? NO
Date of disclosure 02/04/2026
Contact name Société Générale - Disclosure team
Telephone number +33 1 42 14 92 74
Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory
Information Service.
Ap31
NOTES ON FORM 8.3
1. See the definition of "connected fund manager" in
Rule 2.2 of Part A of the Rules.
2. See the definition of "interest in a relevant
security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of
Part B of the Rules.
3. See the definition of "relevant securities" in Rule
2.1 of Part A of the Rules.
4. See the definition of "dealing" in Rule 2.1 of Part
A of the Rules.
5. If the economic exposure to changes in the price of
securities is limited, for example, by virtue of a stop loss arrangement
relating to a spread bet, full details must be given.
6. See Rule 2.5(d) of Part A of the Rules.
7. If details included in a disclosure under Rule 8
are incorrect, they should be corrected as soon as practicable in a subsequent
disclosure. Such disclosure should state clearly that it corrects details
disclosed previously, identify the disclosure or disclosures being corrected,
and provide sufficient detail for the reader to understand the nature of the
corrections. In the case of any doubt, the Panel should be consulted.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
References in these notes to "the Rules" are to the Irish Takeover Panel Act,
1997, Takeover Rules, 2022.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ITPLLLFBQZLLBBK
Copyright 2019 Regulatory News Service, all rights reservedRecent news on BAWAG AG
See all newsREG - T.Rowe Price Assoc BAWAG Group AG - Form 8.3 - Bawag Group AG
AnnouncementREG - Societe Generale SA BAWAG Group AG - Form 8.3 - BAWAG Group AG
AnnouncementREG - Irish Takeover Panel - Disclosure Table
AnnouncementREG - T.Rowe Price Assoc BAWAG Group AG - Form 8.3 - Bawag Group AG
AnnouncementREG - T.Rowe Price Assoc BAWAG Group AG - Form 8.3 - Bawag Group AG
Announcement